A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified by immune checkpoint inhibition

By afschroeder • December 10, 2025

Johnsen NA, Carlisle R, Baghoomian W, Pierce JL, Nguyen MO. A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified by immune checkpoint inhibition. JAAD Case Rep. 2025 Oct 27;67:36-39. doi: 10.1016/j.jdcr.2025.10.025. PMID: 41362852; PMCID: PMC12681758.

Tags: acute generalized exanthematous pustulosis, acute localized exanthematous pustulosis, cutaneous immune-related adverse event, Dermatology, Drug reaction, drug-induced exanthem, immune checkpoint inhibitor, injection site reaction, pembrolizumab, Publications, pustules, Resident

Xenium spatial transcriptomics identifies mesenchymal fibroblast expansion and conserved fibrotic ECM programs in keloid

Deng M, Brewer GM, Espinoza A, Orellana-Montes J, Hedayatyanfard K, Hu C, Jahan MGS, Deriss M, Davis JC, Cheng CE, Pellegrini M, Agak GW. Xenium[...]

Trends in MD-PhD representation and match outcomes across competitive specialties, 2007-2024

Zhou AE, Klufas T, Choi E, Kim YW, Kim JJ, Sarfo A, Sloan B, Feng H. Trends in MD-PhD representation and match outcomes across competitive[...]

Ethical Considerations of Cosmetic GLP-1 Receptor Agonist Prescribing in Dermatology

Jonnalagadda A, Lowry WP, Pathak GN, Choi E, Zhou AE, Grant-Kels JM. Ethical Considerations of Cosmetic GLP-1 Receptor Agonist Prescribing in Dermatology. Clin Dermatol. 2026[...]